New directions for anti-emetic research
- 1 September 1994
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 5 (7) , 569-570
- https://doi.org/10.1093/oxfordjournals.annonc.a058924
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Oral granisetron alone and in combination with dexamethasone: A double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesisAnnals of Oncology, 1994
- Cisplatin-induced delayed emesis: Pattern and prognostic factors during three subsequent cyclesAnnals of Oncology, 1994
- Enantioselective inhibition of ampomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99,994Neuropharmacology, 1994
- The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferretEuropean Journal of Pharmacology, 1993
- Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron?BMJ, 1991
- Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapyThe Lancet, 1991
- Neuropharmacology of emesis induced by anti-cancer therapyTrends in Pharmacological Sciences, 1988